Evaluation of the effects of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR‐Preserved Trial-Reference-Cited by-同舟云学术

Evaluation of the effects of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR‐Preserved Trial

Published:2019-09-16 Issue:10 Volume:21 Page:1279-1287
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:Eur J Heart Fail

Author:

Anker Stefan D.¹,Butler Javed²,Filippatos Gerasimos S.³⁴,Jamal Waheed⁵,Salsali Afshin⁶,Schnee Janet⁶,Kimura Karen⁷,Zeller Cordula⁸,George Jyothis⁵,Brueckmann Martina⁵⁹,Zannad Faiez¹⁰,Packer Milton¹¹¹²,Packer Milton,Anker Stefan D.,Butler Javed,Filippatos Gerasimos S.,Zannad Faiez,George Jyothis,Brueckmann Martina,Perrone Sergio,Nicholls Stephen,Janssens Stefan,Bocchi Edmar,Giannetti Nadia,Verma Subodh,Jian Zhang,Gomez Mesa Juan Esteban,Spinar Jindrich,Böhm Michael,Merkely Bela,Chopra Vijay,Senni Michele,Taddi Stefano,Tsutsui Hiroyuki,Chuquiure Eduardo,La Rocca Hans Pieter Brunner,Ponikowski Piotr,Vinereanu Dragos,Sim David,Choi Dong‐Ju,Juanatey Jose Ramon Gonzalez,Squire Iain,Butler Javed,Januzzi James,Pina Ileana,Pocock Stuart J.,Carson Peter,Doehner Wolfram,Miller Alan,Haas Markus,Pehrson Steen,Komajda Michel,Anand Inder,Teerlink John,Rabinstein Alejandro,Steiner Thorsten,Kamel Hooman,Tsivgoulis Georgios,Lewis James,Freston James,Kaplowitz Neil,Mann Johannes,Petrie Mark,Bernstein Richard,Cheung Alfred,Green Jennifer,Januzzi James,Kaul Sanjay,Ping Carolyn Lam Su,Lip Gregory,Marx Nikolaus,McCullough Peter,Mehta Cyrus,Ponikowski Piotr,Rosenstock Julio,Sattar Naveed,Scirica Benjamin,Tsutsui Hiroyuki,Verma Subodh,Wanner Christoph,Welty Francine K.,Parhofer Klaus G.,Clayton Tim,Pedersen Terje R.,Lees Kennedy R.,Konstam Marvin A.,Greenberg Barry,Palmer Mike,

Affiliation:

1. Department of Cardiology (CVK) and Berlin Institute of Health Centre for Regenerative Therapies (BCRT) German Centre for Cardiovascular Research (DZHK) Partner Site Berlin Germany

2. University of Mississippi School of Medicine Jackson MI USA

3. School of Medicine, National and Kapodistrian University of Athens Athens University Hospital Attikon Athens Greece

4. School of Medicine University of Cyprus Nicosia Cyprus

5. Boehringer Ingelheim International GmbH Ingelheim Germany

6. Boehringer Ingelheim Pharmaceuticals, Inc. Ridgefield CT USA

7. Boehringer Ingelheim Canada Ltd Burlington ON Canada

8. Boehringer Ingelheim Pharma GmbH & Co. KG Biberach Germany

9. Faculty of Medicine Mannheim University of Heidelberg Mannheim Germany

10. Inserm INI‐CRCT, CHRU, University of Lorraine Nancy France

11. Baylor Heart and Vascular Institute Baylor University Medical Center Dallas TX USA

12. Imperial College London UK

Publisher